Lactobacilli and bifidobacteria derived from infant intestines may activate macrophages and lead to different IL-10 secretion

References

• Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627–1640.
   PubMed Web of Science ®Google Scholar
• Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017 Feb;152(2):313–321e2.
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778.
   PubMed Web of Science ®Google Scholar
• Yen HH, Weng MT, Tung CC, et al. Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study. Intest Res. 2019 Jan;17(1):54–62.
   PubMed Web of Science ®Google Scholar
• Burisch J, Jess T, Martinato M, et al. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013 May;7(4):322–337.
   PubMed Web of Science ®Google Scholar
• Martinez C, Antolin M, Santos J, et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol. 2008 Mar;103(3):643–648.
   PubMed Web of Science ®Google Scholar
• Scanlan PD, Shanahan F, O’Mahony C, et al. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn’s disease. J Clin Microbiol. 2006 Nov;44(11):3980–3988..
   PubMed Web of Science ®Google Scholar
• Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol. 2011 Feb 7;17(5):557–566.
   PubMed Web of Science ®Google Scholar
• McGuckin MA, Eri R, Simms LA, et al. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis. 2009 Jan;15(1):100–113.
   PubMed Web of Science ®Google Scholar
• de Ridder L, Waterman M, Turner D, et al. Use of biosimilars in paediatric inflammatory bowel disease: a position statement of the ESPGHAN paediatric IBD porto group. J Pediatr Gastroenterol Nutr. 2015 Oct;61(4):503–508.
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369(9573):1641–1657.
   PubMed Web of Science ®Google Scholar
• Broekaert IJ, Walker WA. Probiotics and chronic disease. J Clin Gastroenterol. 2006 Mar;40(3):270–274.
   PubMed Web of Science ®Google Scholar
• Mennigen R, Nolte K, Rijcken E, et al. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol-Gastroint Liver Physiol. 2009 May;296(5):G1140–9.
   PubMed Web of Science ®Google Scholar
• Morita H, He F, Fuse T, et al. Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci Biotechnol Biochem. 2002 Sep;66(9):1963–1966.
   PubMed Web of Science ®Google Scholar
• He F, Morita H, Hashimoto H, et al. Intestinal Bifidobacterium species induce varying cytokine production. J Allergy Clin Immunol. 2002 Jun;109(6):1035–1036.
   PubMed Web of Science ®Google Scholar
• Reimers MS, Bastiaannet E, van Herk-sukel MP, et al. Aspirin use after diagnosis improves survival in older adults with colon cancer: a retrospective cohort study. J Am Geriatr Soc. 2012 Dec;60(12):2232–2236.
   PubMed Web of Science ®Google Scholar
• Doherty GA, Bennett GC, Cheifetz AS, et al. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn’s disease. Aliment Pharmacol Ther. 2010 Apr;31(8):802–809.
   PubMed Web of Science ®Google Scholar
• Wildt S, Nordgaard I, Hansen U, et al. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis. J Crohns Colitis. 2011 Apr;5(2):115–121.
   PubMed Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Rahimi F, et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn’s disease. Dig Dis Sci. 2008 Sep;53(9):2524–2531.
   PubMed Web of Science ®Google Scholar
• Franke A, McGovern DPB, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nature Genet. 2010;42(12):1118–1125.
   PubMed Web of Science ®Google Scholar
• Franke A, Balschun T, Karlsen TH, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008 Nov;40(11):1319–1323.
   PubMed Web of Science ®Google Scholar
• Kühn R, Löhler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993 Oct 22;75(2):263–274.
   PubMed Web of Science ®Google Scholar
• Shouval DS, Biswas A, Goettel JA, et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity. 2014 May 15;40(5):706–719.
   PubMed Web of Science ®Google Scholar
• Zigmond E, Bernshtein B, Friedlander G, et al. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity. 2014 May 15;40(5):720–733.
   PubMed Web of Science ®Google Scholar
• Li S, Wan Q, Cheng R, et al. Intestine lactobacilli of 1–4 months infant and characterize their biochemical properties in Chengdu City in 2015-2016. Wei Sheng Yan Jiu. 2018 Sep;47(5):776–781.
   PubMedGoogle Scholar
• Hui-jing L, Qun W, Zi-hao L, et al. Composition and immunomodulatory efferts of intestinal bifidobcateria in infants from Chengdu. Acta Nutrimenta Sinica. 2019 Dec;41(6):568–575.
   Google Scholar
• Hesketh M, Sahin KB, West ZE, et al. Macrophage phenotypes regulate scar formation and chronic wound healing. Int J Mol Sci. 2017 Jul 17;18(7):1545.
   PubMed Web of Science ®Google Scholar
• de Moreno de Leblanc A, Del Carmen S, Zurita-Turk M, et al. Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases. ISRN Gastroenterol. 2011;892971. DOI:10.5402/2011/892971.
   PubMedGoogle Scholar
• Liu W, Chen M, Duo L, et al. Characterization of potentially probiotic lactic acid bacteria and bifidobacteria isolated from human colostrum. J Dairy Sci. 2020 May;103(5):4013–4025.
   PubMed Web of Science ®Google Scholar
• Cheng RY, Yao JR, Wan Q, et al. Oral administration of Bifidobacterium bifidum TMC3115 to neonatal mice may alleviate IgE-mediated allergic risk in adulthood. Benef Microbes. 2018 Sep 18;9(5):815–828.
   PubMed Web of Science ®Google Scholar
• He F, Morita H, Ouwehand AC, et al. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol. 2002;46(11):781–785.
   PubMed Web of Science ®Google Scholar
• Takano T, Endo R, Wang Y, et al. Lactobacillus plantarum OLL2712 induces IL-10 production by intestinal dendritic cells. Biosci Microbiota Food Health. 2020;39(2):39–44.
   PubMed Web of Science ®Google Scholar
• Citar M, Hacin B, Tompa G, et al. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells. Benef Microbes. 2015;6(3):325–336.
   PubMed Web of Science ®Google Scholar
• Weiss G, Christensen HR, Zeuthen LH, et al. Lactobacilli and bifidobacteria induce differential interferon-β profiles in dendritic cells. Cytokine. 2011;56(2):520–530.
   PubMed Web of Science ®Google Scholar
• Latvala S, Miettinen M, Kekkonen RA, et al. Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages. Clin Exp Immunol. 2011 Jul;165(1):94–103.
   PubMed Web of Science ®Google Scholar
• Helwig U, Lammers KM, Rizzello F, et al. Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol. 2006 Oct 7;12(37):5978–5986.
   PubMed Web of Science ®Google Scholar
• Symons A, Beinke S, Ley SC. MAP kinase kinase kinases and innate immunity. Trends Immunol. 2006 Jan;27(1):40–48.
   PubMed Web of Science ®Google Scholar
• Baik JE, Jang YO, Kang SS, et al. Differential profiles of gastrointestinal proteins interacting with peptidoglycans from Lactobacillus plantarum and Staphylococcus aureus. Mol Immunol. 2015 May;65(1):77–85.
   PubMed Web of Science ®Google Scholar
• Ahmed-Hassan H, Abdul-Cader MS, Sabry MA, et al. Toll-like receptor (TLR)4 signalling induces myeloid differentiation primary response gene (MYD) 88 independent pathway in avian species leading to type I interferon production and antiviral response. Virus Res. 2018 Sep 2;256:107–116.
   PubMed Web of Science ®Google Scholar
• Lorne E, Dupont H, Abraham E. Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? Intensive Care Med. 2010 Nov;36(11):1826–1835.
   PubMed Web of Science ®Google Scholar
• Li Y, Qu X, Yang H, et al. Bifidobacteria DNA induces murine macrophages activation in vitro. Cell Mol Immunol. 2005 Dec;2(6):473–478.
   PubMed Web of Science ®Google Scholar
• Du Pasquier L, Schwager J, Flajnik MF. The immune system of Xenopus. Annu Rev Immunol. 1989;7:251–275.
   PubMed Web of Science ®Google Scholar
• Yang M, Deng J, Liu Y, et al. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol. 2012 Jun;180(6):2375–2385.
   PubMed Web of Science ®Google Scholar
• Goudy K, Song S, Wasserfall C, et al. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13913–13918.
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen M, Wu R, et al. Suppression of autoimmune diabetes by viral IL-10 gene transfer. J Immunol. 2002 Jun 15;168(12):6479–6485.
   PubMed Web of Science ®Google Scholar
• Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2000 Jun;278(6):G829–33.
   PubMed Web of Science ®Google Scholar
• Imaoka A, Shima T, Kato K, et al. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol. 2008 Apr 28;14(16):2511–2516.
   PubMed Web of Science ®Google Scholar
• Di Giacinto C, Marinaro M, Sanchez M, et al. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol. 2005 Mar 15;174(6):3237–3246.
   PubMed Web of Science ®Google Scholar
• Smits HH, Engering A, van der Kleij D, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005 Jun;115(6):1260–1267.
   PubMed Web of Science ®Google Scholar